Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

886 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Targeting of the glutamine transporter SLC1A5 induces cellular senescence in clear cell renal cell carcinoma.
Kawakami I, Yoshino H, Fukumoto W, Tamai M, Okamura S, Osako Y, Sakaguchi T, Inoguchi S, Matsushita R, Yamada Y, Tatarano S, Nakagawa M, Enokida H. Kawakami I, et al. Among authors: okamura s. Biochem Biophys Res Commun. 2022 Jun 30;611:99-106. doi: 10.1016/j.bbrc.2022.04.068. Epub 2022 Apr 20. Biochem Biophys Res Commun. 2022. PMID: 35487063 Free article.
Characterization and treatment of gemcitabine- and cisplatin-resistant bladder cancer cells with a pan-RAS inhibitor.
Yoshino H, Yokoyama S, Tamai M, Okamura S, Iizasa S, Sakaguchi T, Osako Y, Inoguchi S, Matsushita R, Yamada Y, Nakagawa M, Tatarano S, Tanimoto A, Enokida H. Yoshino H, et al. Among authors: okamura s. FEBS Open Bio. 2023 Jun;13(6):1056-1066. doi: 10.1002/2211-5463.13616. Epub 2023 Apr 29. FEBS Open Bio. 2023. PMID: 37079001 Free PMC article.
Development of a novel treatment based on PKMYT1 inhibition for cisplatin-resistant bladder cancer with miR-424-5p-dependent cyclin E1 amplification.
Fukumoto W, Okamura S, Tamai M, Arima J, Kawahara I, Fukuda I, Mitsuke A, Sakaguchi T, Sugita S, Matsushita R, Tatarano S, Yamada Y, Nakagawa M, Enokida H, Yoshino H. Fukumoto W, et al. Among authors: okamura s. BMC Cancer. 2024 Oct 29;24(1):1333. doi: 10.1186/s12885-024-13109-5. BMC Cancer. 2024. PMID: 39472827 Free PMC article.
PKN1 kinase-negative knock-in mice develop splenomegaly and leukopenia at advanced age without obvious autoimmune-like phenotypes.
Siddique SM, Kubouchi K, Shinmichi Y, Sawada N, Sugiura R, Itoh Y, Uehara S, Nishimura K, Okamura S, Ohsaki H, Kamoshida S, Yamashita Y, Tamura S, Sonoki T, Matsuoka H, Itoh T, Mukai H. Siddique SM, et al. Among authors: okamura s. Sci Rep. 2019 Sep 27;9(1):13977. doi: 10.1038/s41598-019-50419-2. Sci Rep. 2019. PMID: 31562379 Free PMC article.
886 results